10 Low Risk High Reward Stocks Set to Triple by 2030
The market is getting tough these days with increasing interest rates, tense world politics, and inconsistent economic conditions, and investors are constantly looking for opportunities.
Terns Pharmaceuticals Inc. (TERN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Soleus Capital Guy Levy | 8,167,100 | $22,541,196 | +1% | 1.62% |
| 2. | OrbiMed Advisors Samuel Isaly | 7,562,971 | $20,873,800 | 0.5% | |
| 3. | Vivo Capital Albert Cha And Frank Kung | 6,895,746 | $19,032,259 | 2.52% | |
| 4. | Deep Track Capital David Kroin | 5,576,558 | $15,391,300 | 0.5% | |
| 5. | Citadel Investment Group Ken Griffin | 3,907,887 | $10,785,768 | +20% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.87 | 23,314 | $90,229.84 | 47,083 | 2025-06-25 | Filing | |
| $3.95 | 5,000 | $19,732.50 | 15,000 | 2025-06-16 | Filing | |
| $3.72 | 5,000 | $18,600.00 | 10,000 | 2025-06-13 | Filing | |
| $3.75 | 5,000 | $18,750.00 | 5,000 | 2025-06-13 | Filing | |
| $5.11 | 2,250 | $11,497.50 | 2,250 | 2024-11-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.49 | 952 | $2,365.82 | 53,317 | 2025-04-01 | Filing | |
| $5.71 | 4,481 | $25,607.12 | 54,269 | 2025-01-02 | Filing | |
| $5.80 | 9,059 | $52,499.62 | 74,752 | 2025-01-06 | Filing | |
| $5.72 | 8,129 | $46,523.89 | 83,811 | 2025-01-02 | Filing | |
| $5.79 | 8,760 | $50,758.07 | 0 | 2025-01-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,110,105 | $19,623,890 | 0% | |
| 2. | 5,706,632 | $15,750,306 | 0% | |
| 3. | 4,152,156 | $11,459,950 | 0% | |
| 4. | 2,153,969 | $5,945,037 | 0.04% | |
| 5. | 1,971,264 | $5,440,689 | 3.63% |
News See All
12 Best Weight Loss Stocks to Buy According to Hedge Funds
Most people have at some point sought to include weight loss and physical exercise in their daily life.
Hedge Fund and Insider Trading News: David Einhorn, Michael Burry, D.E. Shaw, Hedonova, OP Investment Management, Agecroft Partners, Akamai Technologies, Inc. (AKAM), Duolingo, Inc. (DUOL), and More
David Einhorn’s Greenlight Capital climbed 36.6% last year, finally recouping losses that his flagship fund had posted since 2015.
Hedge Fund and Insider Trading News: Donald Sussman, Sanjay Shah, Scott Bessent, Morgan Creek Capital, Glimpse Group Inc (VRAR), Terns Pharmaceuticals, Inc. (TERN), and More
Hedge funder Donald Sussman sold a waterfront lot in Fort Lauderdale for $17 million to a Texas-based aerospace executive in an off-market deal.
Hedge Fund and Insider Trading News: TimesSquare Capital Management, Hunting Hill Global Capital, Coinbase Global Inc (COIN), Design Therapeutics, Inc. (DSGN), and More
TimesSquare Capital Management, an equity investment management company, released its “U.S. Concentrated Growth Strategy” third-quarter investor letter. A copy of the same can be downloaded here.
Hedge Fund and Insider Trading News: Kyle Bass, Ken Griffin, Mike Novogratz, SkyBridge Capital, Bridgewater Associates, Terns Pharmaceuticals Inc (TERN), Tricida Inc (TCDA), and More
Hedge-fund billionaire Ken Griffin has shattered the Miami price record, shelling out $106.875 million for a waterfront estate.
Should I Avoid Terns Pharmaceuticals, Inc. (TERN)?
With the second-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the third ...